Economic burden of toxicities associated with treating metastatic melanoma in eight countries
Year of publication: |
January 2017
|
---|---|
Authors: | Wehler, Elizabeth ; Zhao, Zhongyun ; Bilir, S. Pinar ; Munakata, Julie ; Barber, Beth |
Published in: |
The European journal of health economics : HEPAC ; health economics in prevention and care. - Berlin : Springer, ISSN 1618-7598, ZDB-ID 2045253-6. - Vol. 18.2017, 1, p. 49-58
|
Subject: | Adverse drug event | Melanoma | Costs and cost analysis | Cost of illness | Gesundheitskosten | Health care costs | Kosten-Nutzen-Analyse | Cost-benefit analysis | Kosten | Costs | Soziale Kosten | Social costs | Krankheit | Disease | Gesundheitsrisiko | Health risk |
-
The costs of poor health habits
Manning, Willard G., (1991)
-
The costs of COVID-19 and the cost-effectiveness of testing
González López-Valcárcel, Beatriz, (2021)
-
Economic burden of lung cancer in Turkey : a cost of illness study from payer perspective
Cicin, Irfan, (2021)
- More ...
-
Bias reduction in estimating long-run relationships from dynamics heterogeneous panels
Pesaran, M. Hashem, (1998)
-
Urban health care reform initiative in China : findings from its pilot experiment in Zhengjiang city
Liu, Gordon G., (1999)
-
Combining opinion surveys with time-series data to forecast the Japanese economy
Hsiao, Cheng, (2000)
- More ...